Literature DB >> 10184168

Development of an Australian drug utilisation database: a report from the Drug Utilization Subcommittee of the Pharmaceutical Benefits Advisory Committee.

D J Edmonds, D M Dumbrell, J G Primrose, P McManus, D J Birkett, V Demirian.   

Abstract

Mesh：

Year:  1993        PMID： 10184168     DOI： 10.2165/00019053-199303060-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  7 in total

1.  Trends in prescribing--the dawn of DUSC.

Authors:  A J Smith
Journal:  Med J Aust       Date:  1990-03-05       Impact factor: 7.738

2.  Economic analysis as an aid to subsidisation decisions: the development of Australian guidelines for pharmaceuticals.

Authors:  D Henry
Journal:  Pharmacoeconomics       Date:  1992-01       Impact factor: 4.981

3.  Drug-coding systems: why so many?

Authors:  S F Hurley; J J McNeil
Journal:  Med J Aust       Date:  1989-09-18       Impact factor: 7.738

4.  Sources of Australian pharmacoepidemiology data.

Authors:  S F Hurley; J J McNeil; C G Berbatis
Journal:  Community Health Stud       Date:  1988

5.  Therapeutic traditions in Northern Ireland, Norway and Sweden: I. Diabetes. WHO Drug Utilization Research Group (DURG).

Authors:  K Griffiths; D G McDevitt; M Andrew; I Baksaas; A Helgeland; J Jervell; P K Lunde; K Oydvin; I Agenäs; U Bergman
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Profiles of antibacterial drug use in Australia and trends from 1987 to 1989. A report from the Drug Utilization Subcommittee of the Pharmaceutical Benefits Advisory Committee.

Authors:  D J Birkett; A S Mitchell; A Godeck; T Grigson; R Cully; C Lee
Journal:  Med J Aust       Date:  1991-09-16       Impact factor: 7.738

7.  Recent trends in the prescribing of cholesterol lowering drugs in Australia. A report from the Drug Utilization Subcommittee of the Pharmaceutical Benefits Advisory Committee.

Authors:  D A Henry; L R Cully; T Grigson; C Lee
Journal:  Med J Aust       Date:  1991-09-02       Impact factor: 7.738
  7 in total
  4 in total

1.  Consumption of anti-infective drugs in Bulgaria for the period from 1979 to 1994.

Authors:  M Popova; P Popova; G Guencheva
Journal:  Pharm World Sci       Date:  1997-04

2.  Modelling the market uptake of new drugs following listing for subsidy in Australia. A report from the Drug Utilisation Subcommittee of the Australian Pharmaceutical Benefits Advisory Committee.

Authors:  D J Birkett; P McManus
Journal:  Br J Clin Pharmacol       Date:  1995-10       Impact factor: 4.335

3.  Compliance with restrictions on the subsidized use of proton pump inhibitors in Australia.

Authors:  P McManus; J Marley; D J Birkett; J Lindner
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

Review 4.  Pharmacoepidemiologic research in Australia: challenges and opportunities for monitoring patients with rheumatic diseases.

Authors:  Christine Y Lu
Journal:  Clin Rheumatol       Date:  2009-02-04       Impact factor: 2.980
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.